Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 1/2013

01-03-2013 | Original Article

An 11-year analysis of the prevalent uropathogens and the changing pattern of Escherichia coli antibiotic resistance in 38,530 community urinary tract infections, Dublin 1999–2009

Authors: I. M. Cullen, R. P. Manecksha, E. McCullagh, S. Ahmad, F. O’Kelly, R. Flynn, T. E. D. McDermott, P. Murphy, R. Grainger, J. P. Fennell, J. A. Thornhill

Published in: Irish Journal of Medical Science (1971 -) | Issue 1/2013

Login to get access

Abstract

Background

Knowledge of local antimicrobial resistance patterns is essential for evidence-based empirical antibiotic prescribing, and a cutoff point of 20 % has been suggested as the level of resistance at which an agent should no longer be used empirically. We sought to identify the changing incidence of causative uropathogens over an 11-year period. We also examined the trends in antibiotic resistance encountered in both the pooled urine samples and those where the causative organism was Escherichia coli.

Patient and methods

A retrospective analysis of the antimicrobial resistance within the positive community urine isolates over the 11-year period, 1999 to 2009, in a single Dublin teaching hospital was performed.

Results

In total 38,530 positive urine samples processed at our laboratory originated in the community of which 23,838 (56.7 %) had E. coli as the infecting organism. The prevalence of E. coli has been increasing in recent years in community UTIs with 70.4 % of UTIs in the community caused by E.coli in 2009. Ampicillin and trimethoprim were the least-active agents against E. coli with mean 11-year resistance rates of 60.8 and 31.5 %, respectively. Significant trends of increasing resistance over the 11-year period were identified for trimethoprim, co-amoxyclav, cefuroxime and gentamicin. Ciprofloxacin remains a reasonable empirical antibiotic choice in this community with an 11-year resistance rate of 10.6 %. Higher antibiotic resistance rates were identified in the male population and in children.

Conclusion

Resistance rates to commonly prescribed antibiotics are increasing significantly. This data will enable evidence-based empirical prescribing which will ensure more effective treatment and lessen the emergence of resistant uropathogens in the community.
Literature
1.
go back to reference Warren JW (2001) Practice guidelines for the treatment of uncomplicated cystitis. Curr Urol Rep 2(4):326–329PubMedCrossRef Warren JW (2001) Practice guidelines for the treatment of uncomplicated cystitis. Curr Urol Rep 2(4):326–329PubMedCrossRef
2.
go back to reference Ronald A (2003) The etiology of urinary tract infection: traditional and emerging pathogens. Dis Mon 49(2):71–82PubMedCrossRef Ronald A (2003) The etiology of urinary tract infection: traditional and emerging pathogens. Dis Mon 49(2):71–82PubMedCrossRef
3.
go back to reference Koeijers JJ, Verbon A, Kessels AG et al (2010) Urinary tract infection in male general practice patients: uropathogens and antibiotic susceptibility. Urology 76(2):336–340PubMedCrossRef Koeijers JJ, Verbon A, Kessels AG et al (2010) Urinary tract infection in male general practice patients: uropathogens and antibiotic susceptibility. Urology 76(2):336–340PubMedCrossRef
4.
5.
go back to reference Kennedy KM, Glynn LG, Dineen B (2010) A survey of the management of urinary tract infection in children in primary care and comparison with the NICE guidelines. BMC Fam Pract 11:6PubMedCrossRef Kennedy KM, Glynn LG, Dineen B (2010) A survey of the management of urinary tract infection in children in primary care and comparison with the NICE guidelines. BMC Fam Pract 11:6PubMedCrossRef
6.
go back to reference Karlowsky JA, Kelly LJ, Thornsberry C et al (2002) Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. Antimicrob Agents Chemother 46(8):2540–2545PubMedCrossRef Karlowsky JA, Kelly LJ, Thornsberry C et al (2002) Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. Antimicrob Agents Chemother 46(8):2540–2545PubMedCrossRef
7.
go back to reference den Heijer CD, Donker GA, Maes J et al (2010) Antibiotic susceptibility of unselected uropathogenic Escherichia coli from female Dutch general practice patients: a comparison of two surveys with a 5 year interval. J Antimicrob Chemother 65(10):2128–2133CrossRef den Heijer CD, Donker GA, Maes J et al (2010) Antibiotic susceptibility of unselected uropathogenic Escherichia coli from female Dutch general practice patients: a comparison of two surveys with a 5 year interval. J Antimicrob Chemother 65(10):2128–2133CrossRef
8.
go back to reference Gobernado M, Valdes L, Alos JI et al (2007) Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain. Rev Esp Quimioter 20(1):68–76PubMed Gobernado M, Valdes L, Alos JI et al (2007) Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain. Rev Esp Quimioter 20(1):68–76PubMed
9.
go back to reference Gupta K, Hooton TM, Wobbe CL et al (1999) The prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in young women. Int J Antimicrob Agents 11(3–4):305–308PubMedCrossRef Gupta K, Hooton TM, Wobbe CL et al (1999) The prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in young women. Int J Antimicrob Agents 11(3–4):305–308PubMedCrossRef
11.
go back to reference Chulain MN, Murray AM, Corbett-Feeney G et al (2005) Antimicrobial resistance in E. coli associated with urinary tract infection in the west of Ireland. Ir J Med Sci 174(4):6–9PubMedCrossRef Chulain MN, Murray AM, Corbett-Feeney G et al (2005) Antimicrobial resistance in E. coli associated with urinary tract infection in the west of Ireland. Ir J Med Sci 174(4):6–9PubMedCrossRef
12.
go back to reference Kahlmeter G, Menday P, Cars O (2003) Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection. J Antimicrob Chemother 52(6):1005–1010PubMedCrossRef Kahlmeter G, Menday P, Cars O (2003) Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection. J Antimicrob Chemother 52(6):1005–1010PubMedCrossRef
13.
go back to reference Kahlmeter G (2003) Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe: the ECO.SENS study. Int J Antimicrob Agents 22(Suppl 2):49–52PubMedCrossRef Kahlmeter G (2003) Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe: the ECO.SENS study. Int J Antimicrob Agents 22(Suppl 2):49–52PubMedCrossRef
14.
go back to reference Zhanel GG, Hisanaga TL, Laing NM et al (2006) Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents 27(6):468–475PubMedCrossRef Zhanel GG, Hisanaga TL, Laing NM et al (2006) Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents 27(6):468–475PubMedCrossRef
16.
go back to reference Community European (1999) COUNCIL RESOLUTION of 8 June on antibiotic resistance: a strategy against the microbial threat. Off J Eur Commun C195:01 Community European (1999) COUNCIL RESOLUTION of 8 June on antibiotic resistance: a strategy against the microbial threat. Off J Eur Commun C195:01
17.
18.
go back to reference Bean DC, Krahe D, Wareham DW (2008) Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005–2006. Ann Clin Microbiol Antimicrob 7:13PubMedCrossRef Bean DC, Krahe D, Wareham DW (2008) Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005–2006. Ann Clin Microbiol Antimicrob 7:13PubMedCrossRef
19.
go back to reference Hutchings F, Jadresic L (2010) GPs should evaluate all children following UTI. Practitioner 254(1731):17-9, 21, 2 Hutchings F, Jadresic L (2010) GPs should evaluate all children following UTI. Practitioner 254(1731):17-9, 21, 2
20.
go back to reference Zorc JJ, Kiddoo DA, Shaw KN (2005) Diagnosis and management of pediatric urinary tract infections. Clin Microbiol Rev 18(2):417–422PubMedCrossRef Zorc JJ, Kiddoo DA, Shaw KN (2005) Diagnosis and management of pediatric urinary tract infections. Clin Microbiol Rev 18(2):417–422PubMedCrossRef
Metadata
Title
An 11-year analysis of the prevalent uropathogens and the changing pattern of Escherichia coli antibiotic resistance in 38,530 community urinary tract infections, Dublin 1999–2009
Authors
I. M. Cullen
R. P. Manecksha
E. McCullagh
S. Ahmad
F. O’Kelly
R. Flynn
T. E. D. McDermott
P. Murphy
R. Grainger
J. P. Fennell
J. A. Thornhill
Publication date
01-03-2013
Publisher
Springer-Verlag
Published in
Irish Journal of Medical Science (1971 -) / Issue 1/2013
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-012-0834-5

Other articles of this Issue 1/2013

Irish Journal of Medical Science (1971 -) 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine